28 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  A Metabolomics Approach to Identify Metabolites Associated with Mortality in Patients Receiving Maintenance Hemodialysis - Solaf Al Awadhi, Leslie Myint, Eliseo Guallar, Clary B. Clish, Kendra E. Wulczyn, Sahir Kalim, Ravi Thadhani, Dorry L. Segev, Mara McAdams DeMarco, Sharon M. Moe, Ranjani N. Moorthi, Thomas H. Hostetter, Jonathan Himmelfarb, Timothy W. Meyer, Neil R. Powe, Marcello Tonelli, Eugene P. Rhee, Tariq Shafi Kidney Int Reports
  Uremic toxins contributing to increased risk of death remain largely unknown. We used untargeted metabolomics to identify plasma metabolites associated with mortality in patients receiving maintenance hemodialysis. (Kidney International Reports (2024))
• 00:00
  Activating the Flozin Shield: Cardioprotective Effects of SGLT2 Inhibitors in Kidney Transplant Recipients with Diabetes Mellitus - Krishnam Raju Penmatsa, Thangamani Muthukumar Kidney Int Reports
  Diabetic kidney disease (DKD), an all-encompassing term that includes both micro and macrovascular complications, is the leading cause of end-stage kidney disease worldwide. Post-transplant diabetes mellitus (PTDM), a common complication following solid organ transplantation, is associated with (…) (Kidney International Reports (2024))
• 00:00
  Validation of a Clinical Scale for Early Detection of Infections at the Exit Site of Central Venous Catheters for Haemodialysis - José Luis Cobo-Sánchez, Ian Blanco-Mavillard, Raquel Pelayo-Alonso, Noelia Mancebo-Salas, Ismael Fernández-Fernández, Irene Larrañeta-Inda, Ana Ulzurrun-García, Isidro Sánchez-Villar, Fernando González-García, Julia Hernando-García, Ma Jesús Rollán-de la Sota, Luís Miguel Vieira-Barbosa Lopes, Ma del Rosario Prieto-Rebollo, Carolina Sesmero-Ramos, Catalina Jaume-Riutort, Rafael Casas-Cuesta, Mateo Alcántara-Crespo, Joan Ernest de Pedro-Gómez Kidney Int Reports
  Exit-site infections (ESI) of central venous catheters for haemodialysis (CVC-HD) have been associated with early catheter removal and an increased risk of CVC-HD-related bacteraemia. No specific clinical scales to predict ESI have previously been validated. (Kidney International Reports (2024))

27 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Early Intervention, Big Savings: The Future of CKD Management in Thailand - Blake Angell, Vivekanand Jha Kidney Int Reports
  Chronic kidney disease (CKD) is largely preventable and treatable, but its burden continues to grow, particularly in low- and middle-income nations.1 The global kidney health community has long advocated implementing CKD detection and treatment programs, but robust health economic evidence to (…) (Kidney International Reports (2024))
• 00:00
  Immunoadsorption and plasma exchange are comparable in ANCA or anti-GBM removal kinetics. - Marion SALLEE, Noémie RESSEGUIER, Thomas CREPIN, Daniel BERTIN, Dominique BERTRAND, Mickaël BOBOT, Thierry KRUMMEL, Nicolas MAILLARD, Julie MOUSSI-FRANCES, Marion PELLETIER, Pascale POULLIN, Cédric RAFAT, Thomas ROBERT, Benjamin TERRIER, Lionel ROSTAING, Stanislas FAGUER, Noémie JOURDE-CHICHE Kidney Int Reports
  Apheresis allows the fast removal of auto-antibodies in anti-glomerular basement membrane (GBM) disease, and in severe ANCA-associated vasculitis. The CINEVAS study tested whether immunoadsorption (IA) allowed a faster removal of ANCA and/or anti-GBM antibodies than plasma exchanges (PEx). (Kidney International Reports (2024))
• 00:00
  Exploring Apixaban Pharmacokinetics, Pharmacodynamics and Safety in Hemodiafiltration Patients. - Aurema Otero, Elena Rosselló-Palmer, Sergi Codina, Nuria Lloberas, Yurema Martínez, Naiara Santos, Judith Peñafiel, Raúl Rigo-Bonnin, Anna Vidal, Joan Peris, Sebastià Videla, Miguel Hueso Kidney Int Reports
  Direct oral anticoagulants (DOACs) have replaced vitamin K antagonists in the general population with non-valvular atrial fibrillation (NVAF) due to their predictable anticoagulation profile, similar efficacy, and superior safety. However, their benefits remain unclear in dialysis patients since (…) (Kidney International Reports (2024))
• 00:00
  A Randomized Controlled Trial Comparing Automated Peritoneal Dialysis and Hemodialysis for Urgent-Start Dialysis in End-Stage Renal Disease - Haijiao Jin, Wei Fang, Ling Wang, Xiujuan Zang, Yueyi Deng, Guoqing Wu, Ying Li, Xiaonong Chen, Niansong Wang, Gengru Jiang, Zhiyong Guo, Xiaoxia Wang, Yinghui Qi, Shifan Lv, Zhaohui Ni Kidney Int Reports
  Peritoneal dialysis (PD) shows promise for urgent-start dialysis in end-stage renal disease (ESRD), with automated PD (APD) having advantages. However, there is limited multi-center randomized controlled trial (RCT) evidence comparing APD versus temporary hemodialysis (HD) for this indication in (…) (Kidney International Reports (2024))
• 00:00
  Design and rationale of the Phase 2 Baricitinib study in APOL1-mediated kidney disease (JUSTICE) - Opeyemi A. Olabisi, Nadine J. Barrett, Anika Lucas, Maurice Smith, Kenisha Bethea, Karen Soldano, Stephanie Croall, Azita Sadeghpour, Hrishikesh Chakraborty, Myles Wolf Kidney Int Reports
  Individuals of recent West African ancestry develop focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end stage kidney disease (HTN-ESKD) at 4 times the rate of White Americans. Two protein-coding variants of the Apolipoprotein L1 (APOL1) gene, G1 and G2, explain 50% to 70% (…) (Kidney International Reports (2024))

26 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Masked Arginine Vasopressin Deficiency (AVP-D) in a Kidney Transplant Recipient with Post-transplant Lymphoproliferative Disorder - Annie Liu, Lakshmi Nayak, Waihay J. Wong, Inhye E. Ahn, Naoka Murakami Kidney Int Reports
  Post-transplant lymphoproliferative disorder (PTLD) is the second most common cancer to occur after organ transplantation – accounting for approximately 20% of all cancers post-kidney transplant.1 PTLD is most common in gastrointestinal tract (20-30%), followed by central nervous system (CNS) (…) (Kidney International Reports (2024))

24 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Impact of prolonged SARS-CoV-2 dosing interval in hemodialysis patients - Caroline Lamarche, Karthik Tennankore, Lorie Marchitto, William Beabien-Souligny, Rémi Goupil, Annie-Claire Nadeau-Fredette, Lakshman Gunaratnam, Fabrice Mac-Way, Mehdi Benlarbi, Debashree Chatterjee, Alexander Tom, Halima Medjahed, Daniel E. Kaufmann, Andrés Finzi, Rita S. Suri, Réseau Néphrologique Québécois (Quebec Renal Network) COVID-19 Study Investigators Kidney Int Reports
  In their cohort study, Kittrakulrat et al. reported that in patients with advanced chronic kidney disease (CKD), a shorter interval between HBV vaccination doses led to a significantly higher seroconversion rate 1. This finding is in line with our findings on the response rate to SARS-CoV-2 (…) (Kidney International Reports (2024))
• 00:00
  Ethical issues related to early screening programs In Low Resource Settings - Manjusha Yadla, Priyadarshini John, Fong Voon Ken, Urmila Anandh Kidney Int Reports
  Chronic kidney disease (CKD) affects 10% of the global population, with an estimated total of 850 million population with underlying CKD1. According to the report of Global Kidney Atlas by Bello et al, CKD detection programmes are in place in 6% of low income countries and 32% of high income (…) (Kidney International Reports (2024))

21 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Response to “Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients” - Jathurong Kittrakulrat, Natavudh Townamchai, Jakapat Vanichanan Kidney Int Reports
  We read the study submitted by Lamarche et al., which emphasized an impact of a shortened interval between COVID-19 vaccination doses on seroconversion rate among patients on hemodialysis. (Kidney International Reports (2024))
• 00:00
  Prevalence of Mendelian kidney disease among patients with high-risk APOL1 genotypes undergoing commercial genetic testing in the United States - Ronaldo da Silva Francisco, Sumit Punj, Lisa Vincent, Nina Sanapareddy, Vivek Bhalla, Glenn M. Chertow, Dianne Keen-Kim, Vivek Charu Kidney Int Reports
  Among individuals with high-risk APOL1 genotypes, the lifetime risk of developing kidney failure is ?15%, indicating that other genetic variants or non-genetic modifiers likely contribute substantially to an individual patient’s risk of progressive kidney disease. Here we estimate the prevalence (…) (Kidney International Reports (2024))
• 00:00
  Major Bleeding Rates in an International Cohort of Patients with End-Stage Kidney Disease - Catelyn R. Coyle, Lori D. Bash, Dena Rosen Ramey, G. Brandon Atkins, Irina Barash, Murilo Guedes, Roberto Pecoits-Filho, Calvin Andrews, Angelo Karaboyas, Marc Bonaca Kidney Int Reports
  An estimated 2.5 million patients worldwide were being treated for end-stage kidney disease (ESKD) as of 2016.1 The vast majority of patients with ESKD are treated with hemodialysis (HD ?89%) and peritoneal dialysis (PD), however patterns of HD and PD vary internationally.2 Patients with ESKD on (…) (Kidney International Reports (2024))
• 00:00
  The importance of CNV analysis in patients with monogenic kidney disease - Laura R. Claus, Robert F. Ernst, Martin G. Elferink, Hanneke W.M. van Deutekom, Bert van der Zwaag, Albertien M. van Eerde Kidney Int Reports
  Genetic testing can reveal monogenic causes of kidney diseases, offering diagnostic, therapeutic, and prognostic benefits. While single nucleotide variants (SNVs) and copy number variants (CNVs) can result in kidney disease, CNV analysis is not always included in genetic testing. (Kidney International Reports (2024))

20 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Global aHUS Registry Analysis of Patients Switching to Ravulizumab from Eculizumab - Franz Schaefer, Imad Al-Dakkak, Katerina Anokhina, David Cohen, Larry A. Greenbaum, Gema Ariceta Kidney Int Reports
  Atypical hemolytic uremic syndrome (aHUS) is a progressive rare disease that, if untreated, can result in severe organ damage and death. Ravulizumab, a next-generation terminal complement inhibitor, provides immediate, complete, and sustained complement C5 inhibition. Real-world data in patients (…) (Kidney International Reports (2024))
• 00:00
  Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti–Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy - Brad H. Rovin, Pierre M. Ronco, Jack F.M. Wetzels, Sharon G. Adler, Isabelle Ayoub, Philippe Zaoui, Seung Hyeok Han, Jaideep S. Dudani, Houston N. Gilbert, Uptal D. Patel, Paul T. Manser, Julia Jauch-Lembach, Nicola Faulhaber, Rainer Boxhammer, Stefan Ha¨rtle, Ben Sprangers Kidney Int Reports
  Primary membranous nephropathy (PMN) is most often caused by autoantibodies to phospholipase A2 receptor (PLA2R). M-PLACE (NCT04145440) is an open-label, phase 1b/2a study that assessed the safety and efficacy of the fully human anti-CD38 monoclonal antibody felzartamab in high-risk anti-PLA2R+ PMN. (Kidney International Reports (2024))
• 00:00
  APOL1 high-risk genotype is not associated with new or worsening of proteinuria or kidney function decline following COVID-19 vaccination - Sarah E. Nystrom, Karen L. Soldano, Micki Rockett, Somenath Datta, Guojie Li, Daniel Silas, Melanie E. Garrett, Allison E. Ashley-Koch, Opeyemi A. Olabisi Kidney Int Reports
  SARS-CoV-2 infection increases systemic inflammatory cytokines which act as a second-hit driver of APOL1-mediated collapsing glomerulopathy. SARS-CoV-2 vaccination also increases cytokines. Recent reports of new glomerular disease in individuals with APOL1 high-risk genotype (HRG) following (…) (Kidney International Reports (2024))

19 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Pilot study of a web-based tool for real-time adequacy assessment of kidney biopsies - Meysam Ahangaran, Emily Sun, Khang Le, Jiawei Sun, William M. Wang, Tian Herng Tan, Lingkai Yin, Lyle J. Burdine, Zeijko Dvanajscak, Clarissa A. Cassol, Shree Sharma, Vijaya B. Kolachalama Kidney Int Reports
  Kidney biopsies are essential for diagnosing kidney disorders in both native and transplanted kidneys1,2. However, the increasing incidence of biopsies yielding insufficient tissue for diagnosis presents a dual challenge: it strains the healthcare system and endangers patients, who may require (…) (Kidney International Reports (2024))
• 00:00
  Certain Red Yeast Rice Supplements in Japan Cause Acute Tubulointerstitial Injury - Yusuke Murata, Seiichiro Hemmi, Yurie Akiya, Kota Miyasato, Hiroki Kobayashi, Takashi Maruyama, Masanori Abe Kidney Int Reports
  Historically, red yeast rice (Red koji) has been a cornerstone in the culinary and medicinal traditions of East Asia, contributing to the production of alcoholic beverages, fermented foods, and, notably, tofuyo—a fermented tofu delicacy originating from Okinawa, Japan, since the eighteenth (…) (Kidney International Reports (2024))

11 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Timing and Modality of Kidney Replacement Therapy in Children and Adolescents - Julia Thumfart, Steffen Wagner, Marietta Kirchner, Karolis Azukaitis, Aysun K. Bayazit, Lukasz Obrycki, Nur Canpolat, Ipek Kaplan Bulut, Ali Duzova, Ali Anarat, Lucie Bessenay, Rukshana Shroff, Dusan Paripovic, Lale Sever, Cengiz Candan, Francesca Lugani, Alev Yilmaz, Fatos Yalcinkaya, Klaus Arbeiter, Aysel Kiyak, Aleksandra Zurowska, Matthias Galiano, Uwe Querfeld, Anette Melk, Franz Schaefer, 4C Study Group Kidney Int Reports
  The choice and timing of kidney replacement therapy (KRT) is influenced by clinical factors, laboratory features, feasibility issues, family preferences, and clinicians' attitudes. We analyzed the factors associated with KRT modality and timing in a multicenter, multinational prospective (…) (Kidney International Reports (2024))
• 00:00
  Virtual Nephron: Evaluation of a Novel Virtual Reality Educational Tool - Georges N. Nakhoul, Jonathan J. Taliercio, Elias H. Bassil, Susana Arrigain, Jesse D. Schold, Richard Wardrop, John O’Toole, Joseph V. Nally, S. Beth Bierer, John R. Sedor, Ali Mehdi Kidney Int Reports
  Recent technological advancements have allowed for the development of innovative and engaging technological tools. Using funding from the American Society of Nephrology, we developed a 3-dimensional (3D) virtual reality (VR) physiology course entitled Diuretic Action and eLectrolyte transport in (…) (Kidney International Reports (2024))
• 00:00
  Enriched-Culture Polymerase Chain Reaction, a Promising Approach for Diagnosing Tuberculous Peritonitis - Preeyarat Pavatung, Talerngsak Kanjanabuch, Theerachai Thammathiwat, Thunvarat Saejew, Dhammika Leshan Wannigama, Patnarin Kanjanabuch, Gompol Suwanpimolkul, Tanittha Chatsuwan, Nibondh Udomsantisuk, David W. Johnson, The Advisory Board of Peritoneal Dialysis, Nephrology Society of Thailand Kidney Int Reports
  Mycobacterium tuberculosis (TB) peritonitis in patients receiving peritoneal dialysis (PD) carries poor outcomes with reported mortality rates ranging from 15% to 58%.1-4 Although the 2022 International Society for PD Guidelines recommend antituberculous therapy without mandatory PD catheter (…) (Kidney International Reports (2024))
• 00:00
  Is It Prime Time for Neutrophil Gelatinase-Associated Lipocalin? - Lui G. Forni, S. Sudha Mannemuddhu Kidney Int Reports
  “Prediction is very difficult, especially if it is about the future” (Neils Bohr) (Kidney International Reports (2024))
• 00:00
  Trend and Monitoring of Skin Autofluorescence in Patients Receiving Hemodialysis - Natasha J. McIntyre Kidney Int Reports
  All cause and cardiovascular mortality is significantly increased in people receiving maintenance hemodialysis (HD), compared to the general population.1 A contributing factor to the development of vascular damage is the formation and accumulation of advanced glycation end products (AGEs) formed (…) (Kidney International Reports (2024))

10 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Acute Kidney Injury and Hair-Straightening Products - Aurélie Huber, Christine Deffert, Solange Moll, Sophie de Seigneux, Lena Berchtold Kidney Int Reports
  Acute kidney injury (AKI) is common and can affect 8.3% of ambulatory patients and up to 32% of hospitalized patients.1 The main causes of AKI are acute tubular necrosis, and prerenal and acute on chronic renal failure. Recently, Robert et al.2 describe a case of AKI presumed due to (…) (Kidney International Reports (2024))
• 00:00
  Corrigendum to “Atypical Clinical Presentation of Autosomal Recessive Polycystic Kidney Mimicking Medullary Sponge Kidney Disease” [Kidney International Reports Volume 7, Issue 4, April 2022, Pages 916-919] - Emmanuel Letavernier, Madeline Schwoehrer, Marine Livrozet, Camille Saint-Jacques, Laure Raymond, Radoslava Saraeva, Jean-Philippe Haymann, Vincent Frochot, Michel Daudon, Laurent Mesnard Kidney Int Reports
  The authors regret that the PKHD1 gene product was incorrectly named “polycystin,” whereas it is known as polyductin or fibrocystin. (Kidney International Reports (2024))

9 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Comprehensive Conservative Care for Kidney Failure - the Need for Evidence-Based Guidance - Olalekan Lee Aiyegbusi Kidney Int Reports
  Kidney failure is an increasing global health challenge.1 Although the precise global prevalence is unknown, there are estimates of as high as 9.7 million affected people.2 In areas where there is access to care, a diagnosis of kidney failure generally connotes a lifetime of dialysis, because (…) (Kidney International Reports (2024))
• 00:00
  Cinacalcet: addressing the unmet clinical need in the management of CKD-MBD in infants on dialysis - Evelien Snauwaert, Agnieszka Prytu?a Kidney Int Reports
  Since the introduction of the first pediatric renal replacement therapy program in the 1960s, the number of infants and young children started on renal replacement therapy has gradually increased, i.e. currently 28.0-32.1 per million age-related population (…) (Kidney International Reports (2024))

7 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Corrigendum to “WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S541] - Anabel Brandoni, María Herminia Hazelhoff, Romina Valeria Campagno, Romina Paula Bulacio, María Fermanda Fussi, Sara María Molinas Kidney Int Reports
  The authors regret that the listing of authors and affiliations were incorrect. These are now correctly listed below. We apologize for any inconvenience caused. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-2021 KNOWLEDGE ATTITUDES AND BELIEFS ABOUT KIDNEY TRANSPLANTATION IN JAMAICAN RESIDENTS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S482] - Davlyn Dewar, Kareen Somers-Brown Kidney Int Reports
  The authors regret that the above abstract was incomplete and is now correctly posted below. We apologize for any inconvenience caused. (Kidney International Reports (2024))

6 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations - Ziad A. Massy, Tilman B. Drueke Kidney Int Reports
  Associations of chronic kidney disease (CKD) with metabolic syndrome and cardiovascular disease (CVD) have long been recognized. Until recently, such associations were mainly limited to interrelationships between either heart and kidney, heart and metabolic syndrome, or metabolic syndrome and (…) (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-218 PRURITUS ASSESSMENT USING A BATTERY OF PATIENT-REPORTED OUTCOME MEASURES IN RUSSIAN PATIENTS WITH CHRONIC KIDNEY DISEASE: PSYCHOMETRIC PROPERTIES OF RUSSIAN VERSIONS AND TESTING OF THEIR USEFULNESS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S52-S53] - Ekaterina PARSHINA, Tatiana Nikitina, Tatiana Ionova, Alexet Tolkach, Mariya Lisova Kidney Int Reports
  The authors regret that the Results text was missing from the above abstract, which is now included below. The authors apologize for any inconvenience caused. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-465 RISK OF MORTALITY IN PATIENTS RECEIVING HIGH-VOLUME ONLINE HEMODIAFILTRATION (OL-HDF) VERSUS HIGH-FLOW HEMODIALYSIS (HD) THERAPY IN 14 FRESENIUS MEDICAL CARE ECUADOR (FMC) CLINICS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S359] - Gabriela Vanessa Tamayo Albán, Jorge Oswaldo Quinchuela Hidalgo, Jadira Natalia Benavides Altamirano Kidney Int Reports
  We regret that the first author’s name was listed in error and should have instead been listed as Gabriela Vanessa Tamayo. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-660 Comparative Analysis of High Flux and Low Flux Dialysis Membranes: In-Situ Synchrotron Imaging and Experimental Ex-Vivo Studies” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S363] - Amira Abdelrasoul, Ahmed Shoker, Jumanah Bahig Kidney Int Reports
  The authors regret that the author names were presented in the wrong order, and should have instead been listed as Jumanah Bahig, Ahmed Shoker, and Amira Abdelrasoul. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-658 Comparative Analysis of Zwitterionic Materials and Polyvinyl Pyrrolidone for Enhancing Dialysis Membrane Hemocompatibility and Psychological Symptoms in Patients” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S362-S363] - Amira Abdelrasoul, Ahmed Shoker, Victoria Doan Kidney Int Reports
  The authors regret that the author names were presented in the wrong order, and should have instead been listed as Victoria Doan, Ahmed Shoker, and Amira Abdelrasoul. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] - Zhiming Ye, Li Fan, Rui Yan, Bicheng Liu, Linghui Zhou, Guangqun Xing, Wei Zhao, Zunsong Wang, Deguang Wang, Min Zhang, Xin Zhang, Xinyu Yang, Xue Yang, Xueqing Yu Kidney Int Reports
  The authors regret that an important part of the Results text was missing from the above abstract, which is now included below. The authors apologize for any inconvenience caused. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-1924 SOCIODEMOGRAPHIC AND CLINICAL PROFILE OF OLDER ADULTS IN A HEMODIALYSIS UNIT IN NORTHEASTERN BRAZIL: CHALLENGES AND PERSPECTIVES” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S282-S283] - Laurisson Costa, Thaisa Valverde, Marcia Juliana Silva, Thiago Mello, Gustavo Presidio, Keila Kamile Sousa Kidney Int Reports
  The authors regret that the Results and Conclusions text was missing from the above abstract, which is now included below. The authors apologize for any inconvenience caused. (Kidney International Reports (2024))

3 juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Bridging the Gap in Genomic Implementation: Identifying User Needs for Precision Nephrology - Jerard Kneifati-Hayek, Teena Zachariah, Wooin Ahn, Atlas Khan, Krzysztof Kiryluk, Sumit Mohan, Chunhua Weng, Ali G. Gharavi, Jordan G. Nestor Kidney Int Reports
  Genomic medicine holds transformative potential for personalized nephrology care; however, its clinical integration poses challenges. Automated clinical decision support (CDS) systems in the electronic health record (EHR) offer a promising solution but have shown limited impact. This study aims (…) (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-1709 NON-CADAVERIC HOMOLOGOUS VEIN AS VASCULAR ACCESS IN A PATIENT WITH EXHAUSTED NATIVE VEINS ON HEMODIALYSIS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S398-S399] - Edwin Castillo Velarde, José A. Ruiz-Peñafiel, Tushar J. Vachharajani Kidney Int Reports
  We regret that the affiliation listed for author Edwin Castillo Velarde was incomplete, and should have instead been listed as INICIB, Instituto de Investigación de Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Perú. (Kidney International Reports (2024))
• 00:00
  Corrigendum to “WCN24-1066 BRIDGING THE GAP: INTEGRATING THE MULTIDISCIPLINARY EQUIPMENT ON HEMODIALYSIS VASCULAR ACCESS FROM LATIN AMERICA AND PERÚ” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S379-S380] - Edwin Castillo Velarde Kidney Int Reports
  We regret that the affiliation listed was incomplete, and should have instead been listed as INICIB, Instituto de Investigación de Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Perú. (Kidney International Reports (2024))

1er juin

Kidney Int Reports http://www.kireports.org/

• 00:00
  Mind the Gap in Kidney Care: Translating What We Know into What We Do - Valerie A. Luyckx, Katherine R. Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W.S. Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A. Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, World Kidney Day Joint Steering Committee Kidney Int Reports
  Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we (…) (Kidney International Reports 9, 6 (2024))